Active10769904Private limited companyLondon

EVERLASTING PHARM LTD

Significant control: Emad Sadeghian (significant control)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Coming soon · product and service lists

What does Everlasting Pharm Ltd sell?

Registered activity: Other human health activities (SIC 86900). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

EVERLASTING PHARM LTD is an active private limited company (company number 10769904) incorporated on 15 May 2017, registered in London. Its registered activity is other human health activities (SIC 86900). Latest small accounts cover the period ending 31 May 2025, showing net assets of £94k and cash of £339k, with 15 employees on average. Net assets fell 88% on the prior period (£756k).

Peer position · net assets

By net assets it sits in the top quarter of 8,029 comparable companies in London (median £1,318, upper quartile £16k).

02

Ownership and control

1 active
  • Mr Emad Sadeghian
    Individual · since 15 May 2017
    • has significant influence or control

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
15 May 20179 yrs ago
Next accounts due
28 February 2027in 128 days
Confirmation statement due
29 May 2027in 218 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 86900
Other human health activities
Accounts type
Total Exemption Full
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 31 May 2025
Net assets
£94k
−88%vs May 2024
Cash at bank
£339k
−51%vs May 2024
Turnover
Not reported
Employees
15
+25%vs May 2024
Net assets
£94k
Cash at bank
£339k
Average employees
15
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 May 2025£94k£339k£459k£996k——15
31 May 2024£756k£687k£0£287k——12
Current ratio0.8Current assets ÷ creditors within one year
Cash per employee£23kCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £93,502 at 31 May 2025
  • Net assets down 25% or more on the prior period-87.6% vs prior period
  • Current assets below creditors within one yearCurrent ratio 0.8
  • Cash at bank of £50,000 or moreCash £338,511
  • Incorporated five or more years agoIncorporated 15 May 2017

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 218 days
  2. Next accounts duein 128 days
  3. Accounts period endNet assets £94k · small accounts
  4. Accounts period endNet assets £756k · small accounts
  5. Incorporated
08

Similar companies in London

Same activity (other human health activities), closest in incorporation date
09

Reminders for EVERLASTING PHARM LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.